FibroBiologics, Leadership Thursday, July 9, 2026 +0.10 Neutral

FibroBiologics Appoints NASA Astronaut Kathleen Rubins to Board

FibroBiologics appointed former NASA astronaut Dr. Kathleen Rubins to its board of directors. Her expertise in space medicine enhances the biotech firm's scientific pipeline for fibroblast-based therapies.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day